Handheld Imaging Devices Market Is Highly Growing in Industry with Good Revenue by 2027

Internal body scans with handheld imaging devices are commonly used to detect various underlying diseases and disorders. These gadgets are portable and are used as needed. Because of the presence of a larger senior population, which is prone to chronic syndromes such as diabetes, brain strokes, and cardiovascular syndromes, as well as increased disposable income in the regions, North America and Asia Pacific are the go-to markets for the portable imaging sector. Ultrasounds are the most profitable imaging product in high-population countries such as India, owing to increased demand in specialist clinics and nurseries for screening of early pregnancy symptoms and uterus-based imbalances.

The demand for medical supplies to care for the afflicted population has increased. Respiratory support equipment, including atomizers, life support machines, oxygen generators, and monitors, are among the most commonly used medical devices in basic clinical care. Furthermore, COVID-19 has resulted in a significant increase in demand for medical goods such as personal protective equipment such as masks, gloves, and protective eyeglasses. Due to an increase in the number of COVID-19 cases worldwide, the demand for medical supplies has surged dramatically among both healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to benefit on the rising demand for medical supplies in order to maintain an appropriate and consistent supply of personal protective equipment in the market. As a result, COVID 19 will have a substantial impact on the global portable imaging device industry.

North America is expected to hold dominant position in the global handheld imaging devices market over the forecast period, owing to increase U.S. Food and Drug Administration (U.S FDA) approvals and introduction of new products in the market. For instance, Smith & Nephew, Inc. received the U.S FDA approval for i: X handheld fluorescence imaging device for detection of bacteria and wound management, in December 2019. The Moleculight i: X increases the chances of clinicians and doctors for identifying any bacterial infection if the bacterial count is over than 104 CFU/g (colony forming unit per gram) and accordingly effective treatment can be provided to the patients.

Moreover, Butterfly Network Inc., launched world’s first ultrasound-on-a-chip based imaging system, Butterfly iQ, in 2017, which is compatible with iPhone. It is used for the diagnosis of 13 clinical applications as it is made by combining 10 thousand sensors, which is an advantage over conventional ultrasound device used for diagnosis.

Some of the key players operating in the global handheld imaging devices market include General Electric Company, Smith & Nephew, Inc., Healcerion, Inc., Micro C, LLC, Hunan Ramzed Medical Imaging Technology Co., Ltd., Siemens, Koninklijke Philips N.V., Butterfly Network, Inc., BLZ Technology Inc., and Kent Imaging INC.